Means and methods for measuring pain and adapted for calculating the level of nociception during general anesthesia or sedation from data including electroencephalogram (EEG), facial electromyogram (EMG), heart rate variability (HRV) by electrocardiogram (ECG) and plethysmography by impedance cardiography (ICG). In a preferred embodiment of this invention the parameters derived from the EEG, the HRV, the plethysmographic curve and the analgetics concentrations are either combined into one index on a scale from 0 to 100, where a high number is associated with high probability of response to noxious stimuli, while a decreasing index is associated with decreasing probability of response to noxious stimuli. Zero (0) indicates extremely low probability of response to noxious stimuli. In an alternative embodiment, only features from the EEG and ECG will be used or only features from EEG, ECG and ICG, to define the fmal index.

A system and method provides closed-loop sedation, anesthesia, or analgesia by monitoring EEG and automatically adjusting the delivery of sedative, anesthetic, and/or analgesic drugs to maintain that desired level of cortical activity for transportation or evacuation of the injured, and for closed-loop anesthesia during surgical care, and at all echelons of care.

A system and method for preliminarily identifying a medical condition in a monitored patient. A predetermined set of patient physiological parameters that are indicative of the presence of a medical condition is monitored. If all of the patient physiological parameters meet a predetermined criteria, a notification is activated that is indicative of the presence of the medical condition. Optionally, users are provided with guidance concerning additional patient physiological parameters to be checked to confirm the presence of the medical condition.

A ventilation system includes an electrochemical filter for depleting alkyl phenols, especially 2,6-diisopropyl phenol, in breathing gas. A method uses the filter for removing alkyl phenols, especially 2,6-diisopropyl phenol, from breathing gas.

The present invention relates to a physiological monitor and system, more particularly to an electroencephalogram (EEG) monitor and system, and a method of detecting the presence or occurrence of suppression in the EEG signal. Accurately detecting signal suppression in real-time provides the clinician with the ability to prevent possibly severe, long-term damage to patients as a result of excessive anesthetic or sedative. The present invention provides such a system and method for accurately and automatically detecting suppression in physiological, particularly EEG, signals in real-time and allowing for the administration of treatment or medication to reverse the effects of such situations, or minimize the harm caused. The present invention also allows for the use of closed-loop treatment or drug delivery systems to further automate the process and provide rapid treatment to a patient to reverse or minimize potential harm.

The present invention relates to a quantitative electroencephalogram (QEEG) monitor and system capable of monitoring and displaying simultaneously neuropathological characteristic and activity of both sides of a subject's brain. The methods include various indices and examination of differences in these indices by which neurophysiological conditions or problems can be identified and treated. These methods, and the systems and devices using these methods preferably can be used for identifying these neurophysiological conditions or brain dysfunction with monitors and methods for seizure detection, for sedation monitoring, for anesthesia monitoring, and the like. These bilateral brain monitoring methods and systems, and the devices using these methods can be used by individuals or clinicians with little or no training in signal analysis or processing. These bilateral monitoring methods can also be used in a range of applications.

A bio-information measuring apparatus bio-information measuring method are provided. The bio-information measuring apparatus includes: a pulse wave obtainer configured to obtain a pulse wave signal, and a processor configured to correct a feature of the obtained pulse wave signal based on a variation in an amplitude of the obtained pulse wave signal, and to measure bio-information based on the corrected feature.

A stimulation current value that causes the supramaximal stimulation according to a subject in the muscle relaxation state is detected. A muscle relaxation monitoring apparatus includes a calibration processing section 4 for performing a calibration process that electrically stimulates a nerve which is an observation portion of a subject, by a predetermined stimulation current value at a predetermined stimulation timing, and that acquires a stimulation current value of a supramaximal stimulation exceeding a maximal stimulation of the subject, based on an amplitude peak value of an electric signal that is based on a stimulation response of a muscle due to the electrical stimulation. The calibration processing section 4 performs, when the subject is in an awake state, the calibration process while using a first stimulation timing that is preset, as the stimulation timing, and performs, when the subject is in a muscle relaxation state, the calibration process while using a second stimulation timing that is longer in period than the first stimulation timing, as the stimulation timing.

An electronic vaporizer system includes an anesthetic sump containing anesthetic agent, a vaporizer unit that vaporizes the anesthetic agent from the sump and delivers the vaporized agent to a patient breathing circuit, and a gas sensor configured to measure end tidal concentration of the anesthetic agent and exhalation gasses from the patient. A control system is configured to receive the measured end tidal concentration of anesthetic agent and compare the measured end tidal concentration to a desired end tidal concentration to be maintained for the patient. The vaporizer unit is then automatically controlled to deliver an amount of vaporized agent to the patient based on the comparison.

The present invention relates to a magnetic resonance imaging system (10), comprising at least one gradient coil (20), and a processing unit (30). The processing unit is configured to control a gradient coil to produce intentional noise for sedation monitoring of a patient.